The position as Team Manager for our Analytical Development team offers a unique possibility to take part in development of Symphogen’s antibody products. We are looking for a candidate with a strong leadership profile to head a team of skilled and dynamic scientists, and to provide input to Symphogens overall CMC development strategies.

We now offer an exciting temporary position for one year, as Senior Scientist/Scientist with shared responsibilities in both the Analytical Support and Analytical Development teams.In the Analytics and Formulation Department, we work with advancing our projects towards from early development to registration and with improving our analytical platform. The successful candidate will support analytical development, - validation and tech transfer to external QC function at CMO.

The position as senior scientist within pharmaceutical development and stability offers a unique possibility to take part in development of Symphogen’s antibody products. You will be involved in late stage pharmaceutical development of drug products including compatibility studies with primary packaging and production materials, stability studies towards BLA filing and support to drug product process characterization.

The position as Technician within the area of Analytical Support is an opportunity for an ex-perienced analytical technician, to work with a wide range of analytical techniques and par-ticipate in projects from early development and through clinical development. Analytical Support is responsible for analysis of both stability samples, process characterization samples, and performs method development and -maturation.

Vil du med på Symphogen' s spændende rejse? Har du flair for at gøre processer mindre manuelle og mere digitaliserede? Vil du gerne arbejde med at skabe fremtidens finansielle rapporteringsværktøjer?

An exciting scientist position within microdroplet assisted antibody cloning and screening is available in the Antibody Discovery department, offering a unique possibility to contribute to optimization of our screening and cloning platform for generation of large therapeutic antibody repertoires.